Antibiotic susceptibility of isolates of Bacillus anthracis, a bacterial pathogen with the potential to be used in biowarfare

Clinical Microbiology and Infection

Volumn 9, Issue 9, 2003, Pages 984-986

  Jones, M E ^a   Goguen, J ^b   Critchley, I A ^a   Draghi, D C ^a   Karlowsky, J A ^a   Sahm, D F ^a   Porschen, R ^c   Patra, G ^d   DelVecchio, V G ^d,e  

^a Focus Technologies Incorporated   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c Focus Technologies   (United States)

^d UNIVERSITY OF SCRANTON   (United States)

^e Vital Probes Inc   (United States)

Author keywords

Antibiotic susceptibility; Bacillus anthracis; Biowarfare

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; CLAVULANIC ACID; DOXYCYCLINE; ERYTHROMYCIN; LINCOSAMIDE DERIVATIVE; MACROLIDE; NALIDIXIC ACID; PENICILLIN G; RIFAMPICIN; STREPTOGRAMIN DERIVATIVE;

ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACILLUS ANTHRACIS; BACTERIUM ISOLATE; BIOLOGICAL WARFARE; IN VITRO STUDY; NONHUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL;

BACILLUS ANTHRACIS; BACTERIA (MICROORGANISMS);

EID: 0141955076     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1469-0691.2003.00775.x     Document Type: Article

References (16)

1. Dixon TC, Meselson M, Guillemin J, Hanna PC. Anthrax. N Engl J Med 1999; 341: 815-26.
2. Cavallo JD, Ramisse F, Girardet M, Vaissaire J, Mock M, Hernandez E. Antibiotic susceptibilities of 96 isolates of Bacillus anthracis isolated in France between 1994 and 2000. Antimicrob Agents Chemother 2002; 46: 2307-9.
3. Choe CH, Bouhaouala SS, Brook I, Elliot TB, Knudson GB. In vitro development of resistance to ofloxacin and doxycycline in Bacillus anthracis Sterne. Antimicrob Agents Chemother 2000; 44: 1766.
4. Brook I, Elliott TB, Pryor HI et al. In vitro resistance of Bacillus anthracis Sterne to doxycycline, macrolides and quinolones. Int J Antimicrob Agents 2001; 18: 559-62.
5. Inglesby TV, O'Toole T, Henderson DA et al. Anthrax as a biological weapon, 2002: updated recommendations for management. JAMA 2002; 1: 2236-52.
6. Patra G, Fouet A, Vaissaire J, Guesdon JL, Mock M. Variation of rRNA operon number as revealed by ribotyping of Bacillus anthracis strains. Res Microbiol 2002; 153: 139-48.
7. Patra G, Vaissaire J, Weber-Levy M, Le Doujet C, Mock M. Molecular characterization of Bacillus strains involved in outbreaks of anthrax in France in 1997. J Clin Microbiol 1998; 36: 3412-4.
8. Turnbull PC, Kramer JM. Bacillus. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds. Manual of clinical microbiology, 6th edn. Washington, DC: ASM Press, 1995: 349.
9. Ramisse V, Patra G, Garrigue H, Guesdon JL, Mock M. Identification and characterization of Bacillus anthracis by multiplex PCR analysis of sequences on plasmids pXO1 and pXO2 and chromosomal DNA. FEMS Microbiol Lett 1996; 145: 9-16.
10. Sastry KS, Tuteja U, Santhosh PK, Lalitha MK, Batra HV. Identification of Bacillus anthracis by a simple protective antigen-specific mAb dot-ELISA. J Med Microbiol 2003; 52: 47-9.
11. Keim P, Price LB, Klevytska AM et al. Multiple-locus variable-number tandem repeat analysis reveals genetic relationships within Bacillus anthracis. J Bacteriol 2000; 182: 2928-36.
12. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing; Twelfth Informational Supplement. M100-S12. Wayne, PA: NCCLS, 2002.
13. Mohammed MJ, Marston CK, Popvic T, Weyant RS, Tenover FC. Antimicrobial susceptibility testing of Bacillus anthracis: comparison of results obtained by using the National Committee for Clinical Laboratory Standards broth microdilution reference and Etest agar gradient diffusion methods. J Clin Microbiol 2002; 40: 1902-7.
14. Centers for Disease Control and Prevention. Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001. MMWR 2001; 50: 909-19.
15. Doganay M, Aydin N. Antimicrobial susceptibility of Bacillus anthracis. Scand J Infect Dis 1991; 23: 333-5.
16. Kim HS, Choi EC, Kim BK. A macrolide-lincosamide-streptogramin B resistance determinant from Bacillus anthracis 590: cloning and expression of ermJ. J Gen Microbiol 1993; 139: 601-7.